HIV/AIDS Clinical Care: Meetings

The Brain, HIV, and Antiretroviral Therapy

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Studies presented at the 2010 Retrovirus Conference add to our knowledge about the neurological effects of HIV infection and the potentially beneficial role of early effective ART.

• By Keith Henry, MD
• March 15, 2010

2009 H1N1 Influenza and HIV Infection

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

HIV infection does not seem to increase the risk for or severity of 2009 H1N1 influenza, according to data presented at the 2010 Retrovirus Conference.

• By Carlos del Rio, MD
• March 15, 2010

Early/Acute HIV Infection

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

The few data presented on this topic at the 2010 Retrovirus Conference revealed important differences between the sexes and potential benefits to early, time-limited treatment.

• By Carlos del Rio, MD
• March 15, 2010

Report from the 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

An expert describes the studies that treating physicians will likely find most interesting.

• By Judith Currier, MD, MSc
• January 11, 2010

ALTAIR — The End of NRTI-Only Regimens

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

In a randomized study, standard combination therapy was preferable to a quadruple-NRTI regimen in terms of both virologic control and adverse effects.

• By Helmut Albrecht, MD
• August 31, 2009

Strategies for Antiretroviral Deintensification

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Data presented at IAS 2009 highlighted new approaches to PI therapy for patients with virologic suppression, including simplifying ritonavir-boosted atazanavir to unboosted atazanavir and trying to sustain suppression using darunavir without nucleosides. Success rates differed among these strategies.

• By Charles B. Hicks, MD
• August 31, 2009

Abacavir and CVD — Again

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

One large study presented at IAS 2009 supported an association between abacavir and cardiovascular risk, but another did not.

• By Paul E. Sax, MD
• August 31, 2009

GSK572 — A "Next-Generation" Integrase Inhibitor?

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Early data presented at IAS 2009 are encouraging.

• By Charles B. Hicks, MD
• August 31, 2009

Nevirapine vs. Boosted Atazanavir — The ARTEN Study

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

The combination of nevirapine + tenofovir + FTC (or 3TC) is safe and effective in treatment-naive patients, according to data presented at IAS 2009.

• By Paul E. Sax, MD
• August 31, 2009

Maternal ART Reduces Transmission of HIV through Breast-Feeding

• HIV/AIDS Clinical Care
• Meeting Report
• Free Article

In a study conducted in Botswana (and reported at IAS 2009), the rate of mother-to-child transmission was only 1% among breast-feeding women who received ART through 6 months postpartum.

• By Judith Feinberg, MD
• August 31, 2009